Articles by : William Newton, Associate Editor/Senior Writer

News Alert

Federal Judge Denies Drugmakers’ Bids to Block Mississippi’s New 340B Contract Pharmacy Access Law

July 3, 2024 William Newton, Associate Editor/Senior Writer Views

U.S. District Judge Halil Ozerden denied separate motions from PhRMA and Novartis to block Mississippi’s 340B contract pharmacy access law.

A federal district judge has rejected two drug industry attempts to block Mississippi’s new state law prohibiting drugmaker 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Missouri GOP Lawmaker Slams State AG’s ‘Irresponsible’ Claims Linking 340B Bill to Abortion As Governor’s Decision Looms

July 2, 2024 William Newton, Associate Editor/Senior Writer Views

Missouri Attorney General Andrew Bailey (R) was rebuked by a GOP state lawmaker for linking a state 340B contract pharmacy bill to abortion.

Missouri Gov. Mike Parson (R) has less than two weeks to decide the fate of a 340B contract pharmacy access [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Supreme Court ‘Chevron’ Ruling Increases Pressure on Congress to Act on 340B But Unlikely to Immediately Impact Program Oversight

July 2, 2024 William Newton, Associate Editor/Senior Writer Views

Hospital groups are urging the Supreme Court to correct what they called HHS' misinterpretation of DSH percentage calculations.

A landmark Supreme Court decision to limit the broad regulatory authority of federal agencies will increase pressure for Congress to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Viatris Becomes 37th Manufacturer to Place Restrictions on 340B Contract Pharmacy Use; Policy Applies to Hospitals and Health Centers

July 2, 2024 William Newton, Associate Editor/Senior Writer Views

Drug manufacturer Viatris has placed 340B contract pharmacy restrictions on hospitals and community health centers.

Canonsburg, Penn.-based Viatris yesterday became the 37th drugmaker to restrict the shipment of 340B-priced drugs in the contract pharmacy setting. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

More Drugmakers Exempt States from Contract Pharmacy Restrictions as Four New State Laws Take Effect

July 2, 2024 William Newton, Associate Editor/Senior Writer Views

Four major drug manufacturers announced they will fully or partially exempt covered entities in certain states from their 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Health Centers Fear ‘Collateral Damage’ From New Manufacturer Restrictions on Wholly-Owned Pharmacies

June 27, 2024 William Newton, Associate Editor/Senior Writer Views

Ohio-based Signature Health will lose 340B drug access at its fully owned central fill pharmacy as a result of five new drugmaker policies.

Five new manufacturer restrictions on wholly-owned pharmacies taking effect in July will be “disastrous” for certain health center pharmacy arrangements, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Health Centers Urge Federal Appeals Court to Reverse Dismissal of Suit Alleging Drugmaker Collusion on Contract Pharmacy Restrictions

June 27, 2024 William Newton, Associate Editor/Senior Writer Views

plaintiff table in a courtroom

Two community health centers urged a federal appeals court to reverse an earlier dismissal of their lawsuit alleging four major [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

IRA Could ‘Crush the 340B Margin,’ Force Transparency into Program, Says Adam Fein of Drug Channels

June 25, 2024 William Newton, Associate Editor/Senior Writer Views

Adam Fein, Ph.D., president of Drug Channels Institute, hosted a June 21 webinar that discussed the IRA's interaction with the 340B program.

The Inflation Reduction Act (IRA) may reduce 340B margins for certain high-cost drugs and drive more transparency into the program, an influential pharmaceutical supply chain analyst who has been a frequent 340B critic told an audience of stakeholders late last

…

PhRMA Asks Federal Judge to Block Enforcement of Maryland’s New 340B Contract Pharmacy Access Law

June 25, 2024 William Newton, Associate Editor/Senior Writer Views

PhRMA filed suit against Maryland's 340B contract pharmacy access law in a federal district court.

A powerful brand-name drug industry trade organization has asked a federal district judge to block Maryland from enforcing the state’s [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

It’s Official: Long-Awaited Final 340B ADR Rule Takes Effect, But Findings Still Distant

June 21, 2024 William Newton, Associate Editor/Senior Writer Views

The U.S. Department of Health and Human Services' final 340B Administrative Dispute Resolution rule formally took effect on June 18.

Fourteen years after the Congressional deadline, the long-anticipated revision to the 340B Administrative Dispute Resolution (ADR) process officially took effect [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live